Compounds > cephalosporin c
Page last updated: 2024-08-24

cephalosporin c and bo 1236

cephalosporin c has been researched along with bo 1236 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashizume, T; Nakagawa, S; Sanada, M; Tanaka, N1
Abruzzo, GK; Fromtling, RA; Gadebusch, HH; Gill, C; Ponticas, S; Shungu, DL; Valiant, ME; Weissberger, BA1
Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME1
Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA1
Hazumi, N; Matsuda, K; Nakagawa, S; Sanada, M; Tanaka, N1

Other Studies

5 other study(ies) available for cephalosporin c and bo 1236

ArticleYear
Comparison of transport pathways of catechol-substituted cephalosporins, BO-1236 and BO-1341, through the outer membrane of Escherichia coli.
    The Journal of antibiotics, 1990, Volume: 43, Issue:12

    Topics: Biological Transport; Biological Transport, Active; Cell Membrane; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Iron; Isoindoles; Molecular Structure; Mutation

1990
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial properties.
    The Journal of antibiotics, 1989, Volume: 42, Issue:5

    Topics: Aerobiosis; Anaerobiosis; Aztreonam; Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Hydrolysis; Isoindoles; Microbial Sensitivity Tests; Molecular Structure; Piperacillin; Pseudomonas aeruginosa; Structure-Activity Relationship

1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
    The Journal of antibiotics, 1989, Volume: 42, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1989
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.
    The Journal of antibiotics, 1989, Volume: 42, Issue:5

    Topics: Animals; Bacterial Infections; Ceftazidime; Cephalosporins; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Half-Life; Isoindoles; Macaca mulatta; Male; Mice; Neutropenia; Pseudomonas Infections

1989
Biological activity of BO-1236, a new antipseudomonal cephalosporin.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7

    Topics: Animals; Bacterial Infections; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoindoles; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1987